"Calroy Health Science’s mission is to develop innovative therapies in the emerging field of the vascular endothelial glycocalyx (EG) and cardiovascular health. The focus of the company’s research and product development efforts target the protection of the endothelium. Calroy is working with academic and medical organizations around the world to advance understanding of how to protect and restore the endothelial glycocalyx. Cellular, animal and human studies have already been conducted to understand the function of the patent-pending glycocalyx regenerating compound (GRC) used in our ground-breaking product, Arterosil HP."
– Calroy Health Sciences
Presented by Dr. Cory Rice, DO
If you have not heard of the endothelial glycocalyx – you are not alone! The glycocalyx is a selective permeability barrier that protects the endothelium and has been shown to play a decisive role in the regulation of the vascular system. In the past 10 years there’s been an explosion of research into the glycocalyx, which is only now entering medical literature.